COMMUNIQUÉS West-GlobeNewswire

DRAFT DECISIONS OF JSC OLAINFARM EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS SUBMITTED BY INITIATORS - ANNA EMĪLIJA MALIGINA UN NIKA SAVEĻJEVA

08/11/2018 - 09:00

Extraordinary General Meeting of Shareholders of Joint Stock Company Olainfarm, requested by the shareholders Anna Emīlija Maligina and Nika Saveļjeva, will be held on November 22nd, 2018, at 11:00 at the premises of [...]

Interim Report, Third Quarter 2018, BioPorto Group

08/11/2018 - 08:53

November 8, 2018 Announcement no. 18 Highlights FDA clearance of The NGAL Test™ expected by mid-2019 In the beginning of October 2018, the U.S. Food and Drug Administration (“FDA”) requested additional data from [...]

111, Inc. Announces Third Quarter 2018 Unaudited Financial Results

08/11/2018 - 08:42

SHANGHAI, China, Nov. 08, 2018 (GLOBE NEWSWIRE) -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results [...]

Saniona signs option agreement with Initiator Pharma

08/11/2018 - 08:30

PRESS RELEASE November 8, 2018 Saniona, a leading biotech company within ion-channel research, today announced that it has entered into a 1-year option agreement with Initiator Pharma A/S, where Initiator Pharma obtains [...]

The first patient included in PledPharma’s global Phase III program for PledOx®

08/11/2018 - 08:00

STOCKHOLM, November 8, 2018 — PledPharma AB (publ), a Swedish pharmaceutical developer, today announced that the first patient has been enrolled in the company’s global Phase III program with the company’s drug [...]

Financial calendar 2019

08/11/2018 - 07:54

Orphazyme A/S Company announcement No. 13/2018 Company Registration No. 32266355 Copenhagen, November 8, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

08/11/2018 - 07:15

IMPLANT 4 trial of nolasiban in IVF starting in Q4 2018, European MAA filing expected late 2019 24-week data from Phase 2b EDELWEISS clinical trial of linzagolix in endometriosis supports 75mg without ABT and 200mg with [...]

VALNEVA Reports Nine Month Results for 2018, Confirms Guidance, Strengthens Balance Sheet with €50m Financing

08/11/2018 - 07:01

Valneva Reports Nine Month Results for 2018, Confirms Guidance, Strengthens Balance Sheet with €50m Financing On track to deliver on multiple key business and R&D milestones €50 million raised in oversubscribed [...]

VALNEVA publie ses résultats pour les neuf premiers mois de l'année 2018, confirme ses prévisions et renforce sa trésorerie avec une récente levée de €50m

08/11/2018 - 07:01

Valneva publie ses résultats pour les neuf premiers mois de l'année 2018, confirme ses prévisions et renforce sa trésorerie avec une récente levée de €50m Validation de multiples jalons opérationnels et R&D en bonne [...]

INNATE PHARMA : Number of shares and voting rights of Innate Pharma as at November 1, 2018

08/11/2018 - 07:01

NUMBER OF SHARES AND VOTING RIGHTS OF Innate Pharma AS AT November 1, 2018 Marseille, France, November 8, 2018, 7:00 AM CET Pursuant to the article L. 233-8 II of the French « Code de Commerce » and the article 223-16 [...]

INNATE PHARMA : Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er novembre 2018

08/11/2018 - 07:01

nouveau NOMBRE D'ACTIONS ET DE DROITS DE VOTE d'InnatE Pharma AU 1 er novembre 2018 Marseille, le 8 novembre 2018, 7h00 CET Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l' [...]

Kiadis Pharma strengthens core team with three senior appointments

08/11/2018 - 07:01

Amsterdam, The Netherlands, November 8, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS) , a clinical-stage biopharmaceutical company, today announces that it has [...]

Amphastar Pharmaceuticals, Inc. Announces Reintroduction of Primatene® MIST

08/11/2018 - 03:55

Primatene ® MIST fills unmet medical need as the only FDA approved over-the-counter asthma inhaler RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced [...]

Vital Therapies Announces Third Quarter 2018 Financial Results

08/11/2018 - 00:20

SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company that has been developing ELAD ® , a cell-based therapy targeting the treatment of acute forms of liver failure, [...]

Precision Optics Corporation Schedules First Quarter Conference Call

07/11/2018 - 23:48

GARDNER, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced that it intends to release its financial results for the fiscal year 2019 first quarter [...]

New England Journal of Medicine publishes positive detailed results from Praluent® (alirocumab) cardiovascular outcomes trial

07/11/2018 - 23:06

New England Journal of Medicine publishes positive detailed results from Praluent ® (alirocumab) cardiovascular outcomes trial Praluent significantly reduced major adverse cardiovascular events by 15% (p<0.001) [...]

Le New England Journal of Medicine publie les résultats positifs détaillés de l'essai clinique consacré à l'effet du Praluent® (alirocumab) sur le risque d'événements cardiovasculaires

07/11/2018 - 23:06

Le New England Journal of Medicine publie les résultats positifs détaillés de l'essai clinique consacré à l'effet du Praluent ® (alirocumab) sur le risque d'événements cardiovasculaires Praluent a significativement [...]

Entasis Therapeutics Announces Zoliflodacin Phase 2 Results Published in The New England Journal of Medicine

07/11/2018 - 23:00

Zoliflodacin Was Well-Tolerated and Successfully Treated Substantially All Uncomplicated Gonorrhea Cases Phase 3 clinical trial, in partnership with GARDP, to begin in 2019 WALTHAM, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE [...]

BioTelemetry, Inc. Elects Stephan Rietiker to its Board of Directors

07/11/2018 - 22:49

MALVERN, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) announced today that Stephan Rietiker has been elected to BioTelemetry’s Board of Directors. Dr. Rietiker was most recently the Chief [...]